請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/56709
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 陳沛隆 | |
dc.contributor.author | Yin-Hung Lin | en |
dc.contributor.author | 林盈宏 | zh_TW |
dc.date.accessioned | 2021-06-16T05:43:33Z | - |
dc.date.available | 2016-10-09 | |
dc.date.copyright | 2014-10-09 | |
dc.date.issued | 2014 | |
dc.date.submitted | 2014-08-11 | |
dc.identifier.citation | 1. Smith, R.J., Bale, J.F., Jr., and White, K.R. (2005). Sensorineural hearing loss in children. Lancet 365, 879-890.
2. Morton, C.C., and Nance, W.E. (2006). Newborn hearing screening--a silent revolution. N Engl J Med 354, 2151-2164. 3. Marazita, M.L., Ploughman, L.M., Rawlings, B., Remington, E., Arnos, K.S., and Nance, W.E. (1993). Genetic epidemiological studies of early-onset deafness in the U.S. school-age population. Am J Med Genet 46, 486-491. 4. Nance, W.E. (2003). The genetics of deafness. Ment Retard Dev Disabil Res Rev 9, 109-119. 5. Kenneson, A., Van Naarden Braun, K., and Boyle, C. (2002). GJB2 (connexin 26) variants and nonsyndromic sensorineural hearing loss: a HuGE review. Genet Med 4, 258-274. 6. Hilgert, N., Smith, R.J., and Van Camp, G. (2009). Forty-six genes causing nonsyndromic hearing impairment: which ones should be analyzed in DNA diagnostics? Mutat Res 681, 189-196. 7. Wu, C.C., Chen, P.J., Chiu, Y.H., Lu, Y.C., Wu, M.C., and Hsu, C.J. (2008). Prospective mutation screening of three common deafness genes in a large Taiwanese Cohort with idiopathic bilateral sensorineural hearing impairment reveals a difference in the results between families from hospitals and those from rehabilitation facilities. Audiol Neurootol 13, 172-181. 8. Chiu, Y.H., Wu, C.C., Lu, Y.C., Chen, P.J., Lee, W.Y., Liu, A.Y., and Hsu, C.J. (2010). Mutations in the OTOF gene in Taiwanese patients with auditory neuropathy. Audiol Neurootol 15, 364-374. 9. Wu, C.C., Yeh, T.H., Chen, P.J., and Hsu, C.J. (2005). Prevalent SLC26A4 mutations in patients with enlarged vestibular aqueduct and/or Mondini dysplasia: a unique spectrum of mutations in Taiwan, including a frequent founder mutation. Laryngoscope 115, 1060-1064. 10. Metzker, M.L. (2010). Sequencing technologies - the next generation. Nat Rev Genet 11, 31-46. 11. Brownstein, Z., Bhonker, Y., and Avraham, K.B. (2012). High-throughput sequencing to decipher the genetic heterogeneity of deafness. Genome Biol 13, 245. 12. Rehman, A.U., Morell, R.J., Belyantseva, I.A., Khan, S.Y., Boger, E.T., Shahzad, M., Ahmed, Z.M., Riazuddin, S., Khan, S.N., Riazuddin, S., et al. (2010). Targeted capture and next-generation sequencing identifies C9orf75, encoding taperin, as the mutated gene in nonsyndromic deafness DFNB79. Am J Hum Genet 86, 378-388. 13. Walsh, T., Shahin, H., Elkan-Miller, T., Lee, M.K., Thornton, A.M., Roeb, W., Abu Rayyan, A., Loulus, S., Avraham, K.B., King, M.C., et al. (2010). Whole exome sequencing and homozygosity mapping identify mutation in the cell polarity protein GPSM2 as the cause of nonsyndromic hearing loss DFNB82. Am J Hum Genet 87, 90-94. 14. Zheng, J., Miller, K.K., Yang, T., Hildebrand, M.S., Shearer, A.E., DeLuca, A.P., Scheetz, T.E., Drummond, J., Scherer, S.E., Legan, P.K., et al. (2011). Carcinoembryonic antigen-related cell adhesion molecule 16 interacts with alpha-tectorin and is mutated in autosomal dominant hearing loss (DFNA4). Proc Natl Acad Sci U S A 108, 4218-4223. 15. Schraders, M., Haas, S.A., Weegerink, N.J., Oostrik, J., Hu, H., Hoefsloot, L.H., Kannan, S., Huygen, P.L., Pennings, R.J., Admiraal, R.J., et al. (2011). Next-generation sequencing identifies mutations of SMPX, which encodes the small muscle protein, X-linked, as a cause of progressive hearing impairment. Am J Hum Genet 88, 628-634. 16. Rehman, A.U., Santos-Cortez, R.L., Morell, R.J., Drummond, M.C., Ito, T., Lee, K., Khan, A.A., Basra, M.A., Wasif, N., Ayub, M., et al. (2014). Mutations in TBC1D24, a gene associated with epilepsy, also cause nonsyndromic deafness DFNB86. Am J Hum Genet 94, 144-152. 17. Azaiez, H., Booth, K.T., Bu, F., Huygen, P., Shibata, S.B., Shearer, A.E., Kolbe, D., Meyer, N., Black-Ziegelbein, E.A., and Smith, R.J. (2014). TBC1D24 Mutation Causes Autosomal-Dominant Nonsyndromic Hearing Loss. Hum Mutat 35, 819-823. 18. Shearer, A.E., DeLuca, A.P., Hildebrand, M.S., Taylor, K.R., Gurrola, J., 2nd, Scherer, S., Scheetz, T.E., and Smith, R.J. (2010). Comprehensive genetic testing for hereditary hearing loss using massively parallel sequencing. Proc Natl Acad Sci U S A 107, 21104-21109. 19. Brownstein, Z., Friedman, L.M., Shahin, H., Oron-Karni, V., Kol, N., Abu Rayyan, A., Parzefall, T., Lev, D., Shalev, S., Frydman, M., et al. (2011). Targeted genomic capture and massively parallel sequencing to identify genes for hereditary hearing loss in Middle Eastern families. Genome Biol 12, R89. 20. De Keulenaer, S., Hellemans, J., Lefever, S., Renard, J.P., De Schrijver, J., Van de Voorde, H., Tabatabaiefar, M.A., Van Nieuwerburgh, F., Flamez, D., Pattyn, F., et al. (2012). Molecular diagnostics for congenital hearing loss including 15 deafness genes using a next generation sequencing platform. BMC Med Genomics 5, 17. 21. Wu, C.C., Lin, Y.H., Lu, Y.C., Chen, P.J., Yang, W.S., Hsu, C.J., and Chen, P.L. (2013). Application of massively parallel sequencing to genetic diagnosis in multiplex families with idiopathic sensorineural hearing impairment. PLoS One 8, e57369. 22. Baek, J.I., Oh, S.K., Kim, D.B., Choi, S.Y., Kim, U.K., Lee, K.Y., and Lee, S.H. (2012). Targeted massive parallel sequencing: the effective detection of novel causative mutations associated with hearing loss in small families. Orphanet J Rare Dis 7, 60. 23. Choi, B.Y., Park, G., Gim, J., Kim, A.R., Kim, B.J., Kim, H.S., Park, J.H., Park, T., Oh, S.H., Han, K.H., et al. (2013). Diagnostic application of targeted resequencing for familial nonsyndromic hearing loss. PLoS One 8, e68692. 24. Mutai, H., Suzuki, N., Shimizu, A., Torii, C., Namba, K., Morimoto, N., Kudoh, J., Kaga, K., Kosaki, K., and Matsunaga, T. (2013). Diverse spectrum of rare deafness genes underlies early-childhood hearing loss in Japanese patients: a cross-sectional, multi-center next-generation sequencing study. Orphanet J Rare Dis 8, 172. 25. Miyagawa, M., Naito, T., Nishio, S.Y., Kamatani, N., and Usami, S. (2013). Targeted exon sequencing successfully discovers rare causative genes and clarifies the molecular epidemiology of Japanese deafness patients. PLoS One 8, e71381. 26. Yang, T., Wei, X., Chai, Y., Li, L., and Wu, H. (2013). Genetic etiology study of the non-syndromic deafness in Chinese Hans by targeted next-generation sequencing. Orphanet J Rare Dis 8, 85. 27. Gao, X., Su, Y., Guan, L.P., Yuan, Y.Y., Huang, S.S., Lu, Y., Wang, G.J., Han, M.Y., Yu, F., Song, Y.S., et al. (2013). Novel compound heterozygous TMC1 mutations associated with autosomal recessive hearing loss in a Chinese family. PLoS One 8, e63026. 28. Su, Y., Tang, W.X., Gao, X., Yu, F., Dai, Z.Y., Zhao, J.D., Lu, Y., Ji, F., Huang, S.S., Yuan, Y.Y., et al. (2014). A novel mutation in the TECTA gene in a Chinese family with autosomal dominant nonsyndromic hearing loss. PLoS One 9, e89240. 29. Li, H., and Durbin, R. (2009). Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760. 30. McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010). The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20, 1297-1303. 31. DePristo, M.A., Banks, E., Poplin, R., Garimella, K.V., Maguire, J.R., Hartl, C., Philippakis, A.A., del Angel, G., Rivas, M.A., Hanna, M., et al. (2011). A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43, 491-498. 32. Wang, K., Li, M., and Hakonarson, H. (2010). ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 38, e164. 33. Kumar, P., Henikoff, S., and Ng, P.C. (2009). Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4, 1073-1081. 34. Adzhubei, I.A., Schmidt, S., Peshkin, L., Ramensky, V.E., Gerasimova, A., Bork, P., Kondrashov, A.S., and Sunyaev, S.R. (2010). A method and server for predicting damaging missense mutations. Nat Methods 7, 248-249. 35. Genomes Project, C., Abecasis, G.R., Auton, A., Brooks, L.D., DePristo, M.A., Durbin, R.M., Handsaker, R.E., Kang, H.M., Marth, G.T., and McVean, G.A. (2012). An integrated map of genetic variation from 1,092 human genomes. Nature 491, 56-65. 36. Robinson, J.T., Thorvaldsdottir, H., Winckler, W., Guttman, M., Lander, E.S., Getz, G., and Mesirov, J.P. (2011). Integrative genomics viewer. Nat Biotechnol 29, 24-26. 37. Thorvaldsdottir, H., Robinson, J.T., and Mesirov, J.P. (2013). Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform 14, 178-192. 38. Untergasser, A., Cutcutache, I., Koressaar, T., Ye, J., Faircloth, B.C., Remm, M., and Rozen, S.G. (2012). Primer3--new capabilities and interfaces. Nucleic Acids Res 40, e115. 39. den Dunnen, J.T., and Antonarakis, S.E. (2000). Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 15, 7-12. 40. Sievers, F., Wilm, A., Dineen, D., Gibson, T.J., Karplus, K., Li, W., Lopez, R., McWilliam, H., Remmert, M., Soding, J., et al. (2011). Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol 7, 539. 41. Kurima, K., Peters, L.M., Yang, Y., Riazuddin, S., Ahmed, Z.M., Naz, S., Arnaud, D., Drury, S., Mo, J., Makishima, T., et al. (2002). Dominant and recessive deafness caused by mutations of a novel gene, TMC1, required for cochlear hair-cell function. Nat Genet 30, 277-284. 42. Donaudy, F., Ferrara, A., Esposito, L., Hertzano, R., Ben-David, O., Bell, R.E., Melchionda, S., Zelante, L., Avraham, K.B., and Gasparini, P. (2003). Multiple mutations of MYO1A, a cochlear-expressed gene, in sensorineural hearing loss. Am J Hum Genet 72, 1571-1577. 43. Eisenberger, T., Di Donato, N., Baig, S.M., Neuhaus, C., Beyer, A., Decker, E., Murbe, D., Decker, C., Bergmann, C., and Bolz, H.J. (2014). Targeted and genomewide NGS data disqualify mutations in MYO1A, the 'DFNA48 gene', as a cause of deafness. Hum Mutat 35, 565-570. 44. Shearer, A.E., Black-Ziegelbein, E.A., Hildebrand, M.S., Eppsteiner, R.W., Ravi, H., Joshi, S., Guiffre, A.C., Sloan, C.M., Happe, S., Howard, S.D., et al. (2013). Advancing genetic testing for deafness with genomic technology. J Med Genet 50, 627-634. 45. Tang, W., Qian, D., Ahmad, S., Mattox, D., Todd, N.W., Han, H., Huang, S., Li, Y., Wang, Y., Li, H., et al. (2012). A low-cost exon capture method suitable for large-scale screening of genetic deafness by the massively-parallel sequencing approach. Genet Test Mol Biomarkers 16, 536-542. 46. Sivakumaran, T.A., Husami, A., Kissell, D., Zhang, W., Keddache, M., Black, A.P., Tinkle, B.T., Greinwald, J.H., Jr., and Zhang, K. (2013). Performance evaluation of the next-generation sequencing approach for molecular diagnosis of hereditary hearing loss. Otolaryngol Head Neck Surg 148, 1007-1016. 47. Shahzad, M., Sivakumaran, T.A., Qaiser, T.A., Schultz, J.M., Hussain, Z., Flanagan, M., Bhinder, M.A., Kissell, D., Greinwald, J.H., Jr., Khan, S.N., et al. (2013). Genetic analysis through OtoSeq of Pakistani families segregating prelingual hearing loss. Otolaryngol Head Neck Surg 149, 478-487. 48. Yang, Z., Gu, L., Romeo, P.H., Bories, D., Motohashi, H., Yamamoto, M., and Engel, J.D. (1994). Human GATA-3 trans-activation, DNA-binding, and nuclear localization activities are organized into distinct structural domains. Mol Cell Biol 14, 2201-2212. 49. Nesbit, M.A., Bowl, M.R., Harding, B., Ali, A., Ayala, A., Crowe, C., Dobbie, A., Hampson, G., Holdaway, I., Levine, M.A., et al. (2004). Characterization of GATA3 mutations in the hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome. J Biol Chem 279, 22624-22634. 50. Ali, A., Christie, P.T., Grigorieva, I.V., Harding, B., Van Esch, H., Ahmed, S.F., Bitner-Glindzicz, M., Blind, E., Bloch, C., Christin, P., et al. (2007). Functional characterization of GATA3 mutations causing the hypoparathyroidism-deafness-renal (HDR) dysplasia syndrome: insight into mechanisms of DNA binding by the GATA3 transcription factor. Hum Mol Genet 16, 265-275. 51. Maquat, L.E. (2004). Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics. Nat Rev Mol Cell Biol 5, 89-99. 52. Labastie, M.C., Catala, M., Gregoire, J.M., and Peault, B. (1995). The GATA-3 gene is expressed during human kidney embryogenesis. Kidney Int 47, 1597-1603. 53. Debacker, C., Catala, M., and Labastie, M.C. (1999). Embryonic expression of the human GATA-3 gene. Mech Dev 85, 183-187. 54. Rivolta, M.N., and Holley, M.C. (1998). GATA3 is downregulated during hair cell differentiation in the mouse cochlea. J Neurocytol 27, 637-647. 55. Van Esch, H., Groenen, P., Nesbit, M.A., Schuffenhauer, S., Lichtner, P., Vanderlinden, G., Harding, B., Beetz, R., Bilous, R.W., Holdaway, I., et al. (2000). GATA3 haplo-insufficiency causes human HDR syndrome. Nature 406, 419-422. 56. Schild, C., Prera, E., Lublinghoff, N., Arndt, S., Aschendorff, A., and Birkenhager, R. (2011). Novel mutation in the homeobox domain of transcription factor POU3F4 associated with profound sensorineural hearing loss. Otol Neurotol 32, 690-694. 57. Vore, A.P., Chang, E.H., Hoppe, J.E., Butler, M.G., Forrester, S., Schneider, M.C., Smith, L.L., Burke, D.W., Campbell, C.A., and Smith, R.J. (2005). Deletion of and novel missense mutation in POU3F4 in 2 families segregating X-linked nonsyndromic deafness. Arch Otolaryngol Head Neck Surg 131, 1057-1063. 58. Lee, H.K., Song, M.H., Kang, M., Lee, J.T., Kong, K.A., Choi, S.J., Lee, K.Y., Venselaar, H., Vriend, G., Lee, W.S., et al. (2009). Clinical and molecular characterizations of novel POU3F4 mutations reveal that DFN3 is due to null function of POU3F4 protein. Physiol Genomics 39, 195-201. 59. Phippard, D., Heydemann, A., Lechner, M., Lu, L., Lee, D., Kyin, T., and Crenshaw, E.B., 3rd. (1998). Changes in the subcellular localization of the Brn4 gene product precede mesenchymal remodeling of the otic capsule. Hear Res 120, 77-85. 60. Phippard, D., Lu, L., Lee, D., Saunders, J.C., and Crenshaw, E.B., 3rd. (1999). Targeted mutagenesis of the POU-domain gene Brn4/Pou3f4 causes developmental defects in the inner ear. J Neurosci 19, 5980-5989. 61. de Kok, Y.J., van der Maarel, S.M., Bitner-Glindzicz, M., Huber, I., Monaco, A.P., Malcolm, S., Pembrey, M.E., Ropers, H.H., and Cremers, F.P. (1995). Association between X-linked mixed deafness and mutations in the POU domain gene POU3F4. Science 267, 685-688. 62. Liu, X., Han, D., Li, J., Han, B., Ouyang, X., Cheng, J., Li, X., Jin, Z., Wang, Y., Bitner-Glindzicz, M., et al. (2010). Loss-of-function mutations in the PRPS1 gene cause a type of nonsyndromic X-linked sensorineural deafness, DFN2. Am J Hum Genet 86, 65-71. 63. Rost, S., Bach, E., Neuner, C., Nanda, I., Dysek, S., Bittner, R.E., Keller, A., Bartsch, O., Mlynski, R., Haaf, T., et al. (2014). Novel form of X-linked nonsyndromic hearing loss with cochlear malformation caused by a mutation in the type IV collagen gene COL4A6. Eur J Hum Genet 22, 208-215. 64. Choi, B.Y., Kim, D.H., Chung, T., Chang, M., Kim, E.H., Kim, A.R., Seok, J., Chang, S.O., Bok, J., Kim, D., et al. (2013). Destabilization and mislocalization of POU3F4 by C-terminal frameshift truncation and extension mutation. Hum Mutat 34, 309-316. 65. Choi, J.W., Min, B., Kim, A., Koo, J.W., Kim, C.S., Park, W.Y., Chung, J., Kim, V., Ryu, Y.J., Kim, S.H., et al. (2014). De Novo Large Genomic Deletions Involving POU3F4 in Incomplete Partition Type III Inner Ear Anomaly in East Asian Populations and Implications for Genetic Counseling. Otol Neurotol. 66. Collin, R.W., Chellappa, R., Pauw, R.J., Vriend, G., Oostrik, J., van Drunen, W., Huygen, P.L., Admiraal, R., Hoefsloot, L.H., Cremers, F.P., et al. (2008). Missense mutations in POU4F3 cause autosomal dominant hearing impairment DFNA15 and affect subcellular localization and DNA binding. Hum Mutat 29, 545-554. 67. Weiss, S., Gottfried, I., Mayrose, I., Khare, S.L., Xiang, M., Dawson, S.J., and Avraham, K.B. (2003). The DFNA15 deafness mutation affects POU4F3 protein stability, localization, and transcriptional activity. Mol Cell Biol 23, 7957-7964. 68. Vahava, O., Morell, R., Lynch, E.D., Weiss, S., Kagan, M.E., Ahituv, N., Morrow, J.E., Lee, M.K., Skvorak, A.B., Morton, C.C., et al. (1998). Mutation in transcription factor POU4F3 associated with inherited progressive hearing loss in humans. Science 279, 1950-1954. 69. Xiang, M., Gao, W.Q., Hasson, T., and Shin, J.J. (1998). Requirement for Brn-3c in maturation and survival, but not in fate determination of inner ear hair cells. Development 125, 3935-3946. 70. Lee, H.K., Park, H.J., Lee, K.Y., Park, R., and Kim, U.K. (2010). A novel frameshift mutation of POU4F3 gene associated with autosomal dominant non-syndromic hearing loss. Biochem Biophys Res Commun 396, 626-630. 71. Pauw, R.J., van Drunen, F.J., Collin, R.W., Huygen, P.L., Kremer, H., and Cremers, C.W. (2008). Audiometric characteristics of a Dutch family linked to DFNA15 with a novel mutation (p.L289F) in POU4F3. Arch Otolaryngol Head Neck Surg 134, 294-300. 72. Kim, H.J., Won, H.H., Park, K.J., Hong, S.H., Ki, C.S., Cho, S.S., Venselaar, H., Vriend, G., and Kim, J.W. (2013). SNP linkage analysis and whole exome sequencing identify a novel POU4F3 mutation in autosomal dominant late-onset nonsyndromic hearing loss (DFNA15). PLoS One 8, e79063. 73. Freitas, E.L., Oiticica, J., Silva, A.G., Bittar, R.S., Rosenberg, C., and Mingroni-Netto, R.C. (2014). Deletion of the entire POU4F3 gene in a familial case of autosomal dominant non-syndromic hearing loss. Eur J Med Genet 57, 125-128. 74. Azaiez, H., Chamberlin, G.P., Fischer, S.M., Welp, C.L., Prasad, S.D., Taggart, R.T., del Castillo, I., Van Camp, G., and Smith, R.J. (2004). GJB2: the spectrum of deafness-causing allele variants and their phenotype. Hum Mutat 24, 305-311. 75. Denoyelle, F., Marlin, S., Weil, D., Moatti, L., Chauvin, P., Garabedian, E.N., and Petit, C. (1999). Clinical features of the prevalent form of childhood deafness, DFNB1, due to a connexin-26 gene defect: implications for genetic counselling. Lancet 353, 1298-1303. 76. Matos, T.D., Caria, H., Simoes-Teixeira, H., Aasen, T., Nickel, R., Jagger, D.J., O'Neill, A., Kelsell, D.P., and Fialho, G. (2007). A novel hearing-loss-related mutation occurring in the GJB2 basal promoter. J Med Genet 44, 721-725. 77. Mani, R.S., Ganapathy, A., Jalvi, R., Srikumari Srisailapathy, C.R., Malhotra, V., Chadha, S., Agarwal, A., Ramesh, A., Rangasayee, R.R., and Anand, A. (2009). Functional consequences of novel connexin 26 mutations associated with hereditary hearing loss. Eur J Hum Genet 17, 502-509. 78. Gandia, M., Del Castillo, F.J., Rodriguez-Alvarez, F.J., Garrido, G., Villamar, M., Calderon, M., Moreno-Pelayo, M.A., Moreno, F., and del Castillo, I. (2013). A novel splice-site mutation in the GJB2 gene causing mild postlingual hearing impairment. PLoS One 8, e73566. 79. Azaiez, H., Yang, T., Prasad, S., Sorensen, J.L., Nishimura, C.J., Kimberling, W.J., and Smith, R.J. (2007). Genotype-phenotype correlations for SLC26A4-related deafness. Hum Genet 122, 451-457. 80. Girotto, G., Abdulhadi, K., Buniello, A., Vozzi, D., Licastro, D., d'Eustacchio, A., Vuckovic, D., Alkowari, M.K., Steel, K.P., Badii, R., et al. (2013). Linkage study and exome sequencing identify a BDP1 mutation associated with hereditary hearing loss. PLoS One 8, e80323. 81. Horn, H.F., Brownstein, Z., Lenz, D.R., Shivatzki, S., Dror, A.A., Dagan-Rosenfeld, O., Friedman, L.M., Roux, K.J., Kozlov, S., Jeang, K.T., et al. (2013). The LINC complex is essential for hearing. J Clin Invest 123, 740-750. 82. Jaworek, T.J., Richard, E.M., Ivanova, A.A., Giese, A.P., Choo, D.I., Khan, S.N., Riazuddin, S., Kahn, R.A., and Riazuddin, S. (2013). An alteration in ELMOD3, an Arl2 GTPase-activating protein, is associated with hearing impairment in humans. PLoS Genet 9, e1003774. 83. Santos-Cortez, R.L., Lee, K., Azeem, Z., Antonellis, P.J., Pollock, L.M., Khan, S., Irfanullah, Andrade-Elizondo, P.B., Chiu, I., Adams, M.D., et al. (2013). Mutations in KARS, encoding lysyl-tRNA synthetase, cause autosomal-recessive nonsyndromic hearing impairment DFNB89. Am J Hum Genet 93, 132-140. 84. Yan, D., Zhu, Y., Walsh, T., Xie, D., Yuan, H., Sirmaci, A., Fujikawa, T., Wong, A.C., Loh, T.L., Du, L., et al. (2013). Mutation of the ATP-gated P2X(2) receptor leads to progressive hearing loss and increased susceptibility to noise. Proc Natl Acad Sci U S A 110, 2228-2233. 85. Zhao, Y., Zhao, F., Zong, L., Zhang, P., Guan, L., Zhang, J., Wang, D., Wang, J., Chai, W., Lan, L., et al. (2013). Exome sequencing and linkage analysis identified tenascin-C (TNC) as a novel causative gene in nonsyndromic hearing loss. PLoS One 8, e69549. 86. Behlouli, A., Bonnet, C., Abdi, S., Bouaita, A., Lelli, A., Hardelin, J.P., Schietroma, C., Rous, Y., Louha, M., Cheknane, A., et al. (2014). EPS8, encoding an actin-binding protein of cochlear hair cell stereocilia, is a new causal gene for autosomal recessive profound deafness. Orphanet J Rare Dis 9, 55. 87. Imtiaz, A., Kohrman, D.C., and Naz, S. (2014). A frameshift mutation in GRXCR2 causes recessively inherited hearing loss. Hum Mutat 35, 618-624. 88. Santos-Cortez, R.L., Lee, K., Giese, A.P., Ansar, M., Amin-Ud-Din, M., Rehn, K., Wang, X., Aziz, A., Chiu, I., Hussain Ali, R., et al. (2014). Adenylate cyclase 1 (ADCY1) mutations cause recessive hearing impairment in humans and defects in hair cell function and hearing in zebrafish. Hum Mol Genet 23, 3289-3298. 89. Seco, C.Z., Oonk, A.M., Dominguez-Ruiz, M., Draaisma, J.M., Gandia, M., Oostrik, J., Neveling, K., Kunst, H.P., Hoefsloot, L.H., Del Castillo, I., et al. (2014). Progressive hearing loss and vestibular dysfunction caused by a homozygous nonsense mutation in CLIC5. Eur J Hum Genet. 90. Zhang, L., Hu, L., Chai, Y., Pang, X., Yang, T., and Wu, H. (2014). A Dominant Mutation in the Stereocilia-Expressing Gene TBC1D24 is a Probable Cause for Nonsyndromic Hearing Impairment. Hum Mutat 35, 814-818. 91. Song, M.H., Lee, H.K., Choi, J.Y., Kim, S., Bok, J., and Kim, U.K. (2010). Clinical evaluation of DFN3 patients with deletions in the POU3F4 locus and detection of carrier female using MLPA. Clin Genet 78, 524-532. 92. Steele-Stallard, H.B., Le Quesne Stabej, P., Lenassi, E., Luxon, L.M., Claustres, M., Roux, A.F., Webster, A.R., and Bitner-Glindzicz, M. (2013). Screening for duplications, deletions and a common intronic mutation detects 35% of second mutations in patients with USH2A monoallelic mutations on Sanger sequencing. Orphanet J Rare Dis 8, 122. 93. Pique, L.M., Brennan, M.L., Davidson, C.J., Schaefer, F., Greinwald, J., Jr., and Schrijver, I. (2014). Mutation analysis of the SLC26A4, FOXI1 and KCNJ10 genes in individuals with congenital hearing loss. PeerJ 2, e384. 94. Aller, E., Jaijo, T., Garcia-Garcia, G., Aparisi, M.J., Blesa, D., Diaz-Llopis, M., Ayuso, C., and Millan, J.M. (2010). Identification of large rearrangements of the PCDH15 gene by combined MLPA and a CGH: large duplications are responsible for Usher syndrome. Invest Ophthalmol Vis Sci 51, 5480-5485. 95. Guo, Y., Sheng, Q., Samuels, D.C., Lehmann, B., Bauer, J.A., Pietenpol, J., and Shyr, Y. (2013). Comparative study of exome copy number variation estimation tools using array comparative genomic hybridization as control. Biomed Res Int 2013, 915636. 96. Tan, R., Wang, Y., Kleinstein, S.E., Liu, Y., Zhu, X., Guo, H., Jiang, Q., Allen, A.S., and Zhu, M. (2014). An evaluation of copy number variation detection tools from whole-exome sequencing data. Hum Mutat 35, 899-907. 97. Shearer, A.E., Kolbe, D.L., Azaiez, H., Sloan, C.M., Frees, K.L., Weaver, A.E., Clark, E.T., Nishimura, C.J., Black-Ziegelbein, E.A., and Smith, R.J. (2014). Copy number variants are a common cause of non-syndromic hearing loss. Genome Med 6, 37. 98. Ye, K., Schulz, M.H., Long, Q., Apweiler, R., and Ning, Z. (2009). Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinformatics 25, 2865-2871. 99. Plagnol, V., Curtis, J., Epstein, M., Mok, K.Y., Stebbings, E., Grigoriadou, S., Wood, N.W., Hambleton, S., Burns, S.O., Thrasher, A.J., et al. (2012). A robust model for read count data in exome sequencing experiments and implications for copy number variant calling. Bioinformatics 28, 2747-2754. 100. Rudnicki, A., and Avraham, K.B. (2012). microRNAs: the art of silencing in the ear. EMBO Mol Med 4, 849-859. 101. Rudnicki, A., Isakov, O., Ushakov, K., Shivatzki, S., Weiss, I., Friedman, L.M., Shomron, N., and Avraham, K.B. (2014). Next-generation sequencing of small RNAs from inner ear sensory epithelium identifies microRNAs and defines regulatory pathways. BMC Genomics 15, 484. 102. Weston, M.D., Pierce, M.L., Rocha-Sanchez, S., Beisel, K.W., and Soukup, G.A. (2006). MicroRNA gene expression in the mouse inner ear. Brain Res 1111, 95-104. 103. Pierce, M.L., Weston, M.D., Fritzsch, B., Gabel, H.W., Ruvkun, G., and Soukup, G.A. (2008). MicroRNA-183 family conservation and ciliated neurosensory organ expression. Evol Dev 10, 106-113. 104. Huntzinger, E., and Izaurralde, E. (2011). Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet 12, 99-110. 105. Mencia, A., Modamio-Hoybjor, S., Redshaw, N., Morin, M., Mayo-Merino, F., Olavarrieta, L., Aguirre, L.A., del Castillo, I., Steel, K.P., Dalmay, T., et al. (2009). Mutations in the seed region of human miR-96 are responsible for nonsyndromic progressive hearing loss. Nat Genet 41, 609-613. 106. Solda, G., Robusto, M., Primignani, P., Castorina, P., Benzoni, E., Cesarani, A., Ambrosetti, U., Asselta, R., and Duga, S. (2012). A novel mutation within the MIR96 gene causes non-syndromic inherited hearing loss in an Italian family by altering pre-miRNA processing. Hum Mol Genet 21, 577-585. 107. Hildebrand, M.S., Witmer, P.D., Xu, S., Newton, S.S., Kahrizi, K., Najmabadi, H., Valle, D., and Smith, R.J. (2010). miRNA mutations are not a common cause of deafness. Am J Med Genet A 152A, 646-652. 108. Lander, E.S., Linton, L.M., Birren, B., Nusbaum, C., Zody, M.C., Baldwin, J., Devon, K., Dewar, K., Doyle, M., FitzHugh, W., et al. (2001). Initial sequencing and analysis of the human genome. Nature 409, 860-921. 109. Chen, J.M., Stenson, P.D., Cooper, D.N., and Ferec, C. (2005). A systematic analysis of LINE-1 endonuclease-dependent retrotranspositional events causing human genetic disease. Hum Genet 117, 411-427. 110. Belancio, V.P., Hedges, D.J., and Deininger, P. (2008). Mammalian non-LTR retrotransposons: for better or worse, in sickness and in health. Genome Res 18, 343-358. 111. Deininger, P. (2011). Alu elements: know the SINEs. Genome Biol 12, 236. 112. Vorechovsky, I. (2010). Transposable elements in disease-associated cryptic exons. Hum Genet 127, 135-154. 113. Kaer, K., and Speek, M. (2013). Retroelements in human disease. Gene 518, 231-241. 114. Polak, P., and Domany, E. (2006). Alu elements contain many binding sites for transcription factors and may play a role in regulation of developmental processes. BMC Genomics 7, 133. 115. Morisada, N., Rendtorff, N.D., Nozu, K., Morishita, T., Miyakawa, T., Matsumoto, T., Hisano, S., Iijima, K., Tranebjaerg, L., Shirahata, A., et al. (2010). Branchio-oto-renal syndrome caused by partial EYA1 deletion due to LINE-1 insertion. Pediatr Nephrol 25, 1343-1348. 116. Knebelmann, B., Forestier, L., Drouot, L., Quinones, S., Chuet, C., Benessy, F., Saus, J., and Antignac, C. (1995). Splice-mediated insertion of an Alu sequence in the COL4A3 mRNA causing autosomal recessive Alport syndrome. Hum Mol Genet 4, 675-679. 117. Bondurand, N., Fouquet, V., Baral, V., Lecerf, L., Loundon, N., Goossens, M., Duriez, B., Labrune, P., and Pingault, V. (2012). Alu-mediated deletion of SOX10 regulatory elements in Waardenburg syndrome type 4. Eur J Hum Genet 20, 990-994. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/56709 | - |
dc.description.abstract | 遺傳性聽力損失是常見的遺傳性疾病,目前已知有超過 100 個基因與聽損有關。基因檢測有助於正確診斷聽損,並精確預估病人預後。然而,傳統的 Sanger 定序檢測技術,均僅能檢測已知且較常見的耳聾基因,因此聽損病人進行基因檢測時,即使是家族史非常明顯的個案,仍有三分之二的聽損家族無法確立基因診斷。近年來,由於次世代定序技術的發展,使未能檢測出常見耳聾基因變異,但家族史明顯之多病例家族,得以同時檢測大量的耳聾基因,解決此檢測技術上之難題。
本研究由台大醫院耳鼻喉部所建立之特發性聽損研究世代中,選取十個未能檢測出<i>GJB2</i> 基因、 <i>SLC26A4</i> 基因與粒線體 12S RNA 基因等常見耳聾基因變異,但家族史明顯之多病例家族,利用次世代定序技術,針對已知 129 個耳聾基因,進行基因變異掃描。我們在 Linux 作業系統 Ubuntu 的環境下,使用BWA、Picard、GATK、ANNOVA、IGV 等軟體建立生物資訊分析流程。其後進行資料過濾,包括:基因變異於族群中之對偶基因頻率須小於百分之五、PolyPhen-2 及 SIFT 等軟體所預測之胺基酸變異致病性分數大於 0.95、直接定序確認、家族譜分析及胺基酸基之演化保留分析等,以釐清所發現之基因變異是否即為導致聽損之真實突變。 我們在十個多病例聽損家族中確認三個導致聽損之基因變異,包括:在一個體染色體顯性遺傳模式的家族中發現 <i>GATA3</i> 基因序列有一個核苷酸的缺失 (c.149delT),導致 p.Phe51LeufsX144 變異、在一個體染色體顯性遺傳模式的家族中發現 <i>POU4F3</i> 基因序列一個核苷酸的改變 (c.982A>G),導致 p.Lys328Glu 變異、以及在一個 X 染色體隱性遺傳模式的家族中發現 <i>POU3F4</i> 基因序列有一個核苷酸的插入 (c.340_341insG),導致 p.Ala116GlyfsX77 變異。此三個變異皆為未曾於文獻上發表之新突變位點。 本研究之結果顯示,次世代定序技術可應用於發現較罕見、以及未知的耳聾基因變異,而可克服當前耳聾基因檢測之技術瓶頸。此一技術之成熟運用,加諸未來可預見其成本將迅速降低,應可成為未來耳聾基因診斷之有力工具,甚至有助於發現新的耳聾基因,進而更深入瞭解聽覺生理及聽損之發生機制。 | zh_TW |
dc.description.abstract | Hereditary hearing impairment (HHI) is a genetically heterogeneous condition with more than 100 deafness genes identified thus far. Despite the clinical utility of genetic diagnosis to address idiopathic sensorineural hearing impairment (SNHI), the current strategy for screening mutations via Sanger sequencing suffers from the limitation that only a limited number of DNA fragments associated with common deafness mutations can be genotyped. Consequently, a definitive genetic diagnosis cannot be achieved in more than two-thirds of families with discernible family history. Recently, the development of next generation sequencing (NGS), which generates millions of DNA sequence reads in parallel during a single experimental run, offers an alternative approach to genetic testing for hereditary hearing impairment.
To investigate the diagnostic utility of NGS, we applied the NGS technique to ten multiplex families with idiopathic SNHI, in which common deafness mutations had previously been tested without positive results. We used NGS to sequence 129 known deafness genes, and applied BWA, Picard, GATK, ANNOVAR, and IGV for bioinformatics analyses. Criteria for data filtering included: allele frequencies <5%, both PolyPhen-2 and SIFT scores >0.95, Sanger sequencing confirmation, segregation pattern compatibility, and evolutionary conservation of amino acid residues. Of the ten multiplex families with idiopathic SNHI, we identified the causative genes/variants for three families. In the proband of an autosomal dominant family with nine affected members, we found a novel single nucleotide deletion mutation, c.149delT, in <i>GATA3</i>. In the proband of an autosomal dominant family with five affected members, we found a novel missense mutation, p.Lys328Glu (c.982A>G), in <i>POU4F3</i>. In the proband of an X-linked recessive family with four affected members, we found a novel single nucleotide insertion mutation, c.340_341insG, in <i>POU3F4</i>. In conclusion, we identified three novel variants as the causative mutations in three families using a NGS-based genetic test. NGS allows genetic diagnosis in multiplex families with idiopathic SNHI by detecting mutations in relatively uncommon deafness genes. With constantly improved technology and drastically reduced cost, NGS can be a powerful tool for achieving molecular diagnosis of hearing impairment and identifying new deafness gene. | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T05:43:33Z (GMT). No. of bitstreams: 1 ntu-103-P01448007-1.pdf: 1203233 bytes, checksum: 451fdfc3992dddbc94874e286ba83fa3 (MD5) Previous issue date: 2014 | en |
dc.description.tableofcontents | 口試委員會審定書 i
誌謝 ii 中文摘要 iii 英文摘要 iv 目錄 vi 圖目錄 viii 表目錄 ix 1 緒論 1 1.1 遺傳性聽損 1 1.2 遺傳性聽損之常見基因變異 1 1.3 遺傳性聽損之直接定序基因檢測 2 1.4 遺傳性耳聾直接定序基因檢測之侷限 2 1.5 次世代定序於遺傳性聽損之應用 3 2 材料與方法 5 2.1 個案之篩選 5 2.2 次世代定序 6 2.3 資料分析 6 2.3.1 BWA-MEM 7 2.3.2 Picard SortSam 7 2.3.3 Picard MarkDuplicates 7 2.3.4 GATK RealignerTargetCreator 和 IndelRealigner 7 2.3.5 Picard FixMateInformation 8 2.3.6 GATK BaseRecalibrator 和PrintReads 8 2.3.7 GATK UnifiedGenotyper 和 VariantFiltration 8 2.3.8 ANNOVAR 9 2.3.9 自動化分析流程 9 2.4 資料過濾 9 2.5 直接定序確認和家族譜分析 10 2.6 胺基酸之演化保留分析 10 3 結果 15 3.1 GATA3 基因變異 15 3.2 POU3F4 基因變異 15 3.3 POU4F3 基因變異 16 3.4 其他基因變異 16 4 討論 22 4.1 次世代定序耳聾基因檢測 22 4.2 GATA3 基因 p.Phe51LeufsX144 變異 23 4.3 POU3F4 基因 p.Ala116GlyfsX77 變異 24 4.4 POU4F3 基因 p.Lys328Glu 變異 25 4.5 次世代定序技術的侷限與未來 30 4.5.1 次世代定序耳聾基因檢測平台的改良 30 4.5.2 微小 RNA 與轉位子偵測 31 4.5.3 變異位點致病性的預測 36 4.6 結語 36 參考文獻 37 附錄 A 50 附錄 B 57 附錄 C 64 | |
dc.language.iso | zh-TW | |
dc.title | 應用次世代定序技術建立遺傳性耳聾基因檢測平台 | zh_TW |
dc.title | Application of Next Generation Sequencing to Establish the Genetic Testing Platform for Hereditary Hearing Impairment | en |
dc.type | Thesis | |
dc.date.schoolyear | 102-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 許權振,楊偉勛 | |
dc.subject.keyword | 聽損,耳聾基因,基因檢測,次世代定序,生物資訊,突變點偵測, | zh_TW |
dc.subject.keyword | hearing impairment,deafness gene,genetic testing,next generation sequencing,bioinformatics,mutation detection, | en |
dc.relation.page | 68 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2014-08-11 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 分子醫學研究所 | zh_TW |
顯示於系所單位: | 分子醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-103-1.pdf 目前未授權公開取用 | 1.18 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。